Alert posted Month-Year | Company | #Alerts | #Win ( > 2%) | #Loss ( < 2% ) | Avg Win% ( > 2%) | #Win ( > 30% ) | Avg Win% ( > 30% ) | Action |
January-2024 | SRPT - Sarepta Therapeutics, Inc. | 1 | 0 | 1 | 0.00% | 0 | 0.00% | View Alerts | ROI Analysis |
|
November-2023 | SRPT - Sarepta Therapeutics, Inc. | 2 | 1 | 1 | 119.64% | 1 | 119.64% | View Alerts | ROI Analysis |
|
May-2023 | SRPT - Sarepta Therapeutics, Inc. | 4 | 3 | 1 | 51.32% | 3 | 51.32% | View Alerts | ROI Analysis |
|
March-2023 | SRPT - Sarepta Therapeutics, Inc. | 15 | 5 | 10 | 100.14% | 5 | 100.14% | View Alerts | ROI Analysis |
|
February-2023 | SRPT - Sarepta Therapeutics, Inc. | 8 | 1 | 7 | 2.94% | 0 | 0.00% | View Alerts | ROI Analysis |
|
January-2023 | SRPT - Sarepta Therapeutics, Inc. | 5 | 3 | 2 | 47.02% | 3 | 47.02% | View Alerts | ROI Analysis |
|
December-2022 | SRPT - Sarepta Therapeutics, Inc. | 3 | 2 | 1 | 95.85% | 2 | 95.85% | View Alerts | ROI Analysis |
|
August-2022 | SRPT - Sarepta Therapeutics, Inc. | 3 | 3 | 0 | 337.90% | 3 | 337.90% | View Alerts | ROI Analysis |
|
July-2022 | SRPT - Sarepta Therapeutics, Inc. | 2 | 1 | 1 | 14.94% | 0 | 0.00% | View Alerts | ROI Analysis |
|
March-2022 | SRPT - Sarepta Therapeutics, Inc. | 3 | 1 | 2 | 67.57% | 1 | 67.57% | View Alerts | ROI Analysis |
|
February-2022 | SRPT - Sarepta Therapeutics, Inc. | 4 | 0 | 4 | 0.00% | 0 | 0.00% | View Alerts | ROI Analysis |
|
January-2022 | SRPT - Sarepta Therapeutics, Inc. | 6 | 2 | 4 | 119.84% | 1 | 236.73% | View Alerts | ROI Analysis |
|
Alert posted Month-Year | Company | #Alerts | #Win ( > 2%) | #Loss ( < 2% ) | Avg Win% ( > 2%) | #Win ( > 30% ) | Avg Win% ( > 30% ) | Action |
December-2021 | SRPT - Sarepta Therapeutics, Inc. | 8 | 5 | 3 | 163.00% | 5 | 163.00% | View Alerts | ROI Analysis |
|
August-2021 | SRPT - Sarepta Therapeutics, Inc. | 12 | 6 | 6 | 96.74% | 3 | 171.30% | View Alerts | ROI Analysis |
|
June-2021 | SRPT - Sarepta Therapeutics, Inc. | 30 | 23 | 7 | 187.41% | 18 | 233.87% | View Alerts | ROI Analysis |
|
May-2021 | SRPT - Sarepta Therapeutics, Inc. | 8 | 7 | 1 | 262.59% | 7 | 262.59% | View Alerts | ROI Analysis |
|
April-2021 | SRPT - Sarepta Therapeutics, Inc. | 2 | 1 | 1 | 231.03% | 1 | 231.03% | View Alerts | ROI Analysis |
|
February-2021 | SRPT - Sarepta Therapeutics, Inc. | 39 | 32 | 7 | 58.99% | 19 | 87.63% | View Alerts | ROI Analysis |
|
January-2021 | SRPT - Sarepta Therapeutics, Inc. | 84 | 60 | 24 | 84.90% | 38 | 125.08% | View Alerts | ROI Analysis |
|
December-2020 | SRPT - Sarepta Therapeutics, Inc. | 37 | 22 | 15 | 170.37% | 19 | 194.67% | View Alerts | ROI Analysis |
|
November-2020 | SRPT - Sarepta Therapeutics, Inc. | 4 | 2 | 2 | 371.96% | 2 | 371.96% | View Alerts | ROI Analysis |
|
October-2020 | SRPT - Sarepta Therapeutics, Inc. | 27 | 10 | 17 | 138.33% | 7 | 193.13% | View Alerts | ROI Analysis |
|
September-2020 | SRPT - Sarepta Therapeutics, Inc. | 43 | 25 | 18 | 46.85% | 14 | 74.56% | View Alerts | ROI Analysis |
|
August-2020 | SRPT - Sarepta Therapeutics, Inc. | 76 | 47 | 29 | 159.73% | 27 | 269.27% | View Alerts | ROI Analysis |
|
Alert posted Month-Year | Company | #Alerts | #Win ( > 2%) | #Loss ( < 2% ) | Avg Win% ( > 2%) | #Win ( > 30% ) | Avg Win% ( > 30% ) | Action |
July-2020 | SRPT - Sarepta Therapeutics, Inc. | 62 | 45 | 17 | 86.61% | 28 | 131.44% | View Alerts | ROI Analysis |
|
June-2020 | SRPT - Sarepta Therapeutics, Inc. | 61 | 34 | 27 | 99.07% | 29 | 113.12% | View Alerts | ROI Analysis |
|
May-2020 | SRPT - Sarepta Therapeutics, Inc. | 40 | 29 | 11 | 116.62% | 27 | 124.82% | View Alerts | ROI Analysis |
|
April-2020 | SRPT - Sarepta Therapeutics, Inc. | 17 | 8 | 9 | 239.94% | 8 | 239.94% | View Alerts | ROI Analysis |
|
March-2020 | SRPT - Sarepta Therapeutics, Inc. | 41 | 26 | 15 | 202.12% | 15 | 337.26% | View Alerts | ROI Analysis |
|
February-2020 | SRPT - Sarepta Therapeutics, Inc. | 20 | 11 | 9 | 120.09% | 10 | 131.86% | View Alerts | ROI Analysis |
|
January-2020 | SRPT - Sarepta Therapeutics, Inc. | 16 | 7 | 9 | 182.89% | 4 | 311.67% | View Alerts | ROI Analysis |
|
December-2019 | SRPT - Sarepta Therapeutics, Inc. | 5 | 3 | 2 | 234.68% | 2 | 337.78% | View Alerts | ROI Analysis |
|
November-2019 | SRPT - Sarepta Therapeutics, Inc. | 7 | 6 | 1 | 101.75% | 4 | 142.94% | View Alerts | ROI Analysis |
|
October-2019 | SRPT - Sarepta Therapeutics, Inc. | 10 | 10 | 0 | 84.40% | 7 | 119.26% | View Alerts | ROI Analysis |
|
September-2019 | SRPT - Sarepta Therapeutics, Inc. | 5 | 5 | 0 | 151.20% | 5 | 151.20% | View Alerts | ROI Analysis |
|
August-2019 | SRPT - Sarepta Therapeutics, Inc. | 6 | 3 | 3 | 606.57% | 3 | 606.57% | View Alerts | ROI Analysis |
|
Alert posted Month-Year | Company | #Alerts | #Win ( > 2%) | #Loss ( < 2% ) | Avg Win% ( > 2%) | #Win ( > 30% ) | Avg Win% ( > 30% ) | Action |
July-2019 | SRPT - Sarepta Therapeutics, Inc. | 26 | 17 | 9 | 87.10% | 9 | 151.28% | View Alerts | ROI Analysis |
|
June-2019 | SRPT - Sarepta Therapeutics, Inc. | 18 | 10 | 8 | 151.66% | 10 | 151.66% | View Alerts | ROI Analysis |
|
May-2019 | SRPT - Sarepta Therapeutics, Inc. | 15 | 12 | 3 | 47.60% | 7 | 68.35% | View Alerts | ROI Analysis |
|
April-2019 | SRPT - Sarepta Therapeutics, Inc. | 8 | 4 | 4 | 56.84% | 4 | 56.84% | View Alerts | ROI Analysis |
|
March-2019 | SRPT - Sarepta Therapeutics, Inc. | 5 | 3 | 2 | 151.68% | 3 | 151.68% | View Alerts | ROI Analysis |
|
February-2019 | SRPT - Sarepta Therapeutics, Inc. | 8 | 6 | 2 | 76.66% | 4 | 106.94% | View Alerts | ROI Analysis |
|
January-2019 | SRPT - Sarepta Therapeutics, Inc. | 9 | 6 | 3 | 101.36% | 6 | 101.36% | View Alerts | ROI Analysis |
|
December-2018 | SRPT - Sarepta Therapeutics, Inc. | 8 | 7 | 1 | 142.86% | 7 | 142.86% | View Alerts | ROI Analysis |
|
November-2018 | SRPT - Sarepta Therapeutics, Inc. | 10 | 9 | 1 | 97.08% | 7 | 122.96% | View Alerts | ROI Analysis |
|
October-2018 | SRPT - Sarepta Therapeutics, Inc. | 11 | 8 | 3 | 118.81% | 7 | 133.17% | View Alerts | ROI Analysis |
|
September-2018 | SRPT - Sarepta Therapeutics, Inc. | 11 | 9 | 2 | 109.16% | 6 | 154.09% | View Alerts | ROI Analysis |
|
August-2018 | SRPT - Sarepta Therapeutics, Inc. | 8 | 7 | 1 | 104.95% | 5 | 140.46% | View Alerts | ROI Analysis |
|
Alert posted Month-Year | Company | #Alerts | #Win ( > 2%) | #Loss ( < 2% ) | Avg Win% ( > 2%) | #Win ( > 30% ) | Avg Win% ( > 30% ) | Action |
July-2018 | SRPT - Sarepta Therapeutics, Inc. | 6 | 4 | 2 | 166.74% | 4 | 166.74% | View Alerts | ROI Analysis |
|
June-2018 | SRPT - Sarepta Therapeutics, Inc. | 3 | 3 | 0 | 100.15% | 3 | 100.15% | View Alerts | ROI Analysis |
|
May-2018 | SRPT - Sarepta Therapeutics, Inc. | 1 | 1 | 0 | 163.14% | 1 | 163.14% | View Alerts | ROI Analysis |
|